Jae-Han Jeon - JoVE Visualize

Showing results (91-100 of 93) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 93 results.

Frontiers in Immunology|May 29, 2019

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 PhenotypeByong-Keol Min, Sungmi Park, Hyeon-Ji Kang, et al.

Diabetes & Metabolism Journal|August 15, 2020

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South KoreaMi Kyung Kim, Jae Han Jeon, Sung Woo Kim, et al.

Endocrinology and Metabolism (Seoul, Korea)|August 22, 2024

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)Nam Hoon Kim, Juneyoung Lee, Suk Chon, et al.

Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 93 results.

Frontiers in Immunology|May 29, 2019

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 PhenotypeByong-Keol Min, Sungmi Park, Hyeon-Ji Kang, et al.

Diabetes & Metabolism Journal|August 15, 2020

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South KoreaMi Kyung Kim, Jae Han Jeon, Sung Woo Kim, et al.

Endocrinology and Metabolism (Seoul, Korea)|August 22, 2024

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)Nam Hoon Kim, Juneyoung Lee, Suk Chon, et al.

Pageof 10